Response to infliximab in atypical pyoderma gangrenosum associated with ulcerative colitis

Am J Gastroenterol. 2008 Nov;103(11):2951-2. doi: 10.1111/j.1572-0241.2008.02094_14.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Colitis, Ulcerative / complications*
  • Colitis, Ulcerative / drug therapy
  • Gastrointestinal Agents / therapeutic use
  • Humans
  • Infliximab
  • Pyoderma Gangrenosum / drug therapy*
  • Pyoderma Gangrenosum / etiology

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Infliximab